Tekla Life Sciences Stock Current Asset
| HQL Stock | USD 13.02 0.03 0.23% |
Tekla Life Sciences fundamentals help investors to digest information that contributes to Tekla Life's financial success or failures. It also enables traders to predict the movement of Tekla Stock. The fundamental analysis module provides a way to measure Tekla Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tekla Life stock.
The value of Non Current Assets Total is estimated to slide to about 339.8 M. The value of Total Current Assets is estimated to slide to about 307.7 K. Tekla | Current Asset |
Tekla Life Sciences Company Current Asset Analysis
Tekla Life's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Tekla Current Asset Historical Pattern
Today, most investors in Tekla Life Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Tekla Life's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Tekla Life current asset as a starting point in their analysis.
Tekla Life Current Asset |
| Timeline |
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
Tekla Total Assets
Total Assets |
|
In accordance with the recently published financial statements, Tekla Life Sciences has a Current Asset of 0.0. This is 100.0% lower than that of the Capital Markets sector and 100.0% lower than that of the Financials industry. The current asset for all United States stocks is 100.0% higher than that of the company.
Tekla Life Current Valuation Drivers
We derive many important indicators used in calculating different scores of Tekla Life from analyzing Tekla Life's financial statements. These drivers represent accounts that assess Tekla Life's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Tekla Life's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 504.6M | 350.8M | 352.8M | 423.1M | 380.8M | 243.8M | |
| Enterprise Value | 505.9M | 350.8M | 352.8M | 423.1M | 380.8M | 244.1M |
Tekla Life ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Tekla Life's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Tekla Life's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Tekla Fundamentals
| Return On Equity | 0.0128 | |||
| Return On Asset | -0.0032 | |||
| Profit Margin | 21.43 % | |||
| Operating Margin | (0.66) % | |||
| Current Valuation | 364.52 M | |||
| Shares Outstanding | 28.06 M | |||
| Shares Owned By Insiders | 0.01 % | |||
| Shares Owned By Institutions | 34.47 % | |||
| Number Of Shares Shorted | 96.46 K | |||
| Price To Earning | 2.84 X | |||
| Price To Book | 0.79 X | |||
| Price To Sales | 91.59 X | |||
| Revenue | 86.69 M | |||
| Gross Profit | 3.98 M | |||
| EBITDA | 22.35 M | |||
| Net Income | 85.3 M | |||
| Cash And Equivalents | 292.4 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 888.61 K | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 1.34 X | |||
| Book Value Per Share | 16.38 X | |||
| Cash Flow From Operations | (12.8 M) | |||
| Short Ratio | 0.38 X | |||
| Earnings Per Share | 3.04 X | |||
| Beta | 0.72 | |||
| Market Capitalization | 364.52 M | |||
| Total Asset | 460.58 M | |||
| Retained Earnings | 44.13 M | |||
| Annual Yield | 0.15 % | |||
| Five Year Return | 8.83 % | |||
| Net Asset | 460.58 M | |||
| Last Dividend Paid | 1.66 |
About Tekla Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tekla Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tekla Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tekla Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Tekla Life Piotroski F Score and Tekla Life Altman Z Score analysis. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Life. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.425 | Dividend Share 1.66 | Earnings Share 3.04 | Revenue Per Share | Quarterly Revenue Growth 0.07 |
The market value of Tekla Life Sciences is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Life's value that differs from its market value or its book value, called intrinsic value, which is Tekla Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Life's market value can be influenced by many factors that don't directly affect Tekla Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.